Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes.

Transl Oncol · 2017 · PMC5614638 · PMID 28946110

Europe PMC DOI

hedged sentence

0.1714

closest p · 3.4× alpha

0.1714

boldest claim

The sentences

did not reach statistical significanceP = .1714not close (p > 0.1)

ER, PR and HER2 positive lesions demonstrated higher contrast enhancement than their receptor negative counterparts, although differences did not reach statistical significance ( P = .1714; P = .3603; P = .2166).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.